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Abstract: 
The discovery of microRNAs (miRNAs) is a remarkable breakthrough in the field of life science, and they are important actors which 
regulate gene expression in diverse cellular processes. Recently, several reports indicated that miRNAs can also target viruses and regulate 
virus replication. Here we discovered 36 pig-encoded miRNAs and 22 human-encoded miRNAs which have putative targets in swine 
influenza virus (SIV) and Swine-Origin 2009 A/H1N1 influenza virus (S-OIV) genes respectively. Interestingly, the putative interactions of 
ssc-miR-124a, ssc-miR-136 and ssc-miR-145 with their SIV target genes had been found to be maintained almost throughout all of the virus 
evolution. Enrichment analysis of previously reported miRNA gene expression profiles revealed that three miRNAs are expressed at higher 
levels in human lung or trachea tissue. The hsa-miR-145 and hsa-miR-92a putatively target the HA gene and hsa-miR-150 putatively targets 
the PB2 gene. Analysis results based on the location distribution from which virus was isolated and sequence conservation imply that some 
putative miRNA-mediated host-virus interactions may characterize the location-specificity.   
 
Keywords: microRNAs (miRNAs), swine influenza virus, target prediction, virus-host interaction 
 
Background: 
MicroRNAs (miRNAs) are a class of ~22 nucleotide (nt) 
evolutionary conserved endogenous non-coding RNAs and believed 
to play important roles in gene regulation by either inactivating or 
degrading mRNA genes [1]. Up to date, more than 9,000 miRNAs 
have been reported in animals, plants and viruses by using 
computational and biological skills. They have been reported to 
participate in the regulation of almost every cellular process [2]. 
Some evidences support that miRNAs play an important role in the 
intricate host-virus interaction network. The early researches 
suggested that some plant miRNAs are involved in plant defense 
and viral offense systems [3]. Later, Lecellier et al. [4] reported that 
human miR-32 could inhibit retrovirus primate foamy virus (PFV) 
replication; Jopling et al. [5] presented that the liver-specific 
miRNA miR-122 could enhance the replication of hepatitis C virus 
(HCV); Murakami et al. [6] found that miR-199a could inhibit HCV 
genome replication; Hariharan et al. [7] predicted candidate targets 
of five human miRNAs in human immunodeficiency virus (HIV); 
Ahluwalia et al. [8] conformed that human miRNA miR-29a could 
down-regulate the expression of Nef protein and interfere with 
HIV-1 replication; And Hakim et al. [9] observed that many human 
microRNAs can target lentiviruses and retroviruses. On the other 
hand, viruses have also evolved to escape host’s RNAi machinery 
by a variety of strategies [10-13].  Though studies into the 
microRNA mediated host-influenza virus interactions are still in its 
infancy, some reports have suggested that miRNAs may be involved 
in anti-flu viral response. Ge et al.  [14, 15] s h o w e d  t h a t  R N A  
interfering (RNAi) could decrease influenza virus production in 
mouse. Matskevich et al.  [16] indicated that human Dicer, an 
enzyme essential for miRNA processing, might inhibit the influenza 
A virus replication. An unpublished data mentioned that two human 
encoded miRNAs miR-136 and miR-507 could target HA and PB2 
genes in influenza A (H5N1) virus [17].  
 
Swine-Origin 2009 A/H1N1 influenza virus (S-OIV) is a newly 
emerged virus which transmitted abroad quickly. More than 10,000 
cases from 56 countries have been diagnosed as 2009 A(H1N1) 
influenza in the world within 2 months. It trends to be thought that 
this S-OIV are homogeneous and similar to North American swine 
A(H1N1) viruses [18]. Traditionally, swine influenza viruses (SIV) 
could cause the swine flu among pigs. But there has been no 
evidence of the S-OIV transmission among the swine up to date. 
Here we reported the discovery of pig miRNAs and human 
miRNAs which putatively target in SIV and S-OIV genes 
respectively. In all of 36 Sus scrofa miRNAs predicted to target 
specific SIV genes, the putative interactions of ssc-miR-124a, 
ssc-miR-136 and ssc-miR-145 with their SIV target genes had been 
found to be maintained throughout virus evolution. In all of 22 
Homo sapiens miRNAs predicted to target specific S-OIV genes, 
hsa-miR-145 and hsa-miR-92a putatively target the HA gene and 
hsa-miR-150 putatively targets the PB2 gene. Analysis of 
previously reported gene expression profiles of miRNAs revealed 
that these three miRNAs are expressed at higher levels in human 
lung or trachea tissue. Analysis results based on the location 
distribution from which virus was isolated and sequence 
conservation imply that some putative miRNA-mediated host-virus 
interactions may characterize the location-specificity. 
 
Methodology: 
Figure 1 depicts the flowchart in the present study. And the 
following description is about the explanation for all the data and 
tools mentioned in this figure: 
 
Datasets: 
885 Homo sapiens and 74 Sus scrofa microRNA mature sequences 
were downloaded from the miRbase database 
(http://microrna.sanger.ac.uk/sequences/, Release 13.0) [19]. The 
Swine-Origin 2009 A/H1N1 influenza virus and the swine influenza 
virus sequences with annotations in GenBank flat file format were 
downloaded from the NCBI Influenza Virus Sequence Database 
(http://www.ncbi.nlm.nih.gov/genomes/FLU/) [20].  
 
MicroRNA expression enrichment analysis: 
Because the respiratory tract is the main organ through that 
influenza virus invades, replicate and spread , all human miRNAs 
expressed in the respiratory tract including oral cavity, larynx, 
pharynx, trachea, bronchus and lung tissue were collected from 
experimental data published in literatures [21, 22] and database [23, 
24]. Data normalized by Z score transformation can be used directly 
in the calculation of significant changes in gene expression between 
different samples and conditions [25]. We used Z scores (Equation 1 
in supplementary material) to compare the expression levels of the 
same miRNA in different tissues, and then sorted all microRNAs 
expressed in a specific tissue by their expression levels. Bioinformation   open access 
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Figure 1: A systematic flowchart in the present study. All the data, software or databases are described in Methodology or Supplementary 
material. 
 
MicroRNA target prediction: 
MiRanda is a dynamic programming global alignment algorithm, 
that places double score on bases 2 - 8 from the 5' end of the 
miRNA [26]. We used this software to initially predict miRNA 
targets with default parameters (Gap Open Penalty: -8.0; Gap 
Extend:-2.0; Score Threshold: 50.0; Energy Threshold: -20.0 
kcal/mol; Scaling Parameter: 2.0). After this initial matching, 
several post-filters were applied: 1. a cutoff score of 120 was used 
according to ref. 7; 2. an exact matching to 5’end seed region 
(positions 2-8) of the mature miRNA was used and the G:U base 
pairing was not allowed. 3. Only the miRNAs which are expressed 
in the human respiratory tract were considered. The third criterion is 
not applied in target identification in SIV genes due to the lack of 
the pig miRNA expression profile data. Bioinformation   open access 
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Figure 2: The putative interactions between swine influenza viruses isolated in different times with the pig miRNAs. The first row shows 
pig miRNAs with putative target sites in SIV genes. The first column shows the different 38 times in which swine influenza viruses were 
isolated (ranging in years from 1931 to 2008). 
 
 
Figure 3: Heat maps of Z-score-normalized microRNA expression profiles in lung and trachea. The Table 3 in supplemental material 
contains miRNA name and corresponding Z scores with the same rank order in this figure. 
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Figure 4: Sequence alignments of the S-OIV HA genes derived from different isolated sources. The T to G, A to G and T to C mutations 
were identified in miR-92a/92b target region and a G to A mutation was identified in miR-145 target region. 
 
Sequence conservation analysis: 
The sequence segments of influenza viruses isolated from different 
patients were aligned using Clustal X [27]. The conservation of 
target sites for the respective miRNAs was analyzed based on these 
alignment results and the mutations in target sites were identified at 
the same time. 
 
 
Discussion: 
Pig microRNAs target in swine influenza virus: 
The top scoring miRNA-target pairs were identified by miRanda 
software with a perfect heptamer match in positions 2-8 of the 
mature miRNA. We found that 36 Sus scrofa miRNAs had putative 
target sites in SIV genes (Figure 2 and Table 1 in supplementary 
material). We collected viral sequences isolated in different 38 years, 
ranging in years from 1931 to 2008. Three putative pig miRNA-SIV Bioinformation   open access 
www.bioinformation.net    Hypothesis
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interactions were found to be maintained almost throughout all the 
swine virus evolution (Figure 2). For example, ssc-miR-124a targets 
the NP genes isolated in all different 38 times, ssc-miR-145 targets 
the NP genes isolated in different 35 times of 38 times and 
ssc-miR-136 targets the NA and NP genes isolated in different 31 
times of 38 times. The influenza A virus nucleoprotein (NP) is a 
single-stranded RNA-binding protein that encapsidates the virus 
genome and has essential functions in viral-RNA synthesis. 
Moreover, the sequences of the NP gene are highly conserved 
across subtypes of influenza virus. There have been reported that 
small interfering RNAs (siRNAs) specific to the nucleocapsid 
protein (NP) gene can inhibit influenza virus production [14, 15].  
 
Human microRNAs target in Swine-Origin 2009 A/H1N1 
influenza virus: 
We used miRanda for identifying human microRNA target sites in 
S-OIV gene sequences with a perfect heptamer match in positions 
2-8 of the mature miRNA. The miRNAs can act as effectors in the 
intricate host-virus interaction networks based on the premise that 
miRNAs expression and virus replication should happen at the same 
cell. Because influenza virus invades，replicates and spreads at the 
respiratory tract in humans, we filtered out miRNAs without 
evidence for expressing in human respiratory tract. And then, we 
identified 22 miRNAs with putative target sites in S-OIV genes. The 
human homologs of ssc-miR-145 and ssc-miR-136, hsa-miR-145 
have putative target sites in S-OIV HA and NP gene whereas 
hsa-miR-136 also has putative target sites in S-OIV NP and NA 
genes (Table 2 in supplementary material). The imprinted miRNA 
miR-136 fully complementary to a retrotransposon-like gene Rtl1 in 
mouse may support this miRNA can also target exogenous nucleic 
acids, as in the case of viruses [28].  
 
Based on Z-score analysis of previously reported gene expression 
profiles of miRNAs [23], three miRNAs with putatively target sites 
on S-OIV genes are expressed at higher levels (top ten significantly 
abundant miRNAs) in human lung or trachea tissue among all 240 
previously studied miRNAs (Figure 3). The miR-145 and miR-92a 
putatively target the HA gene whereas miR-150 putatively targets 
the PB2 gene. HA is known to be critical for pathogenicity of 
influenza virus and immuno-suppression and PB2 is one component 
of ribonucleoprotein which is responsible for virus RNA replication 
and transcription [29]. Analysis results based on the isolated virus 
location distribution and sequence conservation imply that some 
putative miRNA-mediated host-virus interactions characterize the 
location-specificity. For example, putative regulation mediated by 
miR-145 may focus on the virus isolated from Texas State in the 
United States of America and putative regulations mediated by 
miR-92a/92b may focus on virus isolated from the location of Spain 
(Table 1 in supplementary material). Conservation analysis of 
putative miRNA target sites shows that a T to G mutation in 
miR-92a/92b target region and a G to A mutation in miR-145 target 
region affect the perfect match to the seed region of corresponding 
miRNAs (Figure 4).   
 
Conclusion: 
At present, our knowledge about the miRNAs’ role in viral 
infections is still in its infancy. Genome-wide prediction of 
miRNA-virus interaction by computational skills may present some 
important clues for anti-virus defense. In summary, our study 
implies that human and pig miRNAs have the potential to affect the 
expression of S-OIV and SIV genes. Whether or not any of these 
interactions mediated by the host cellular miRNAs to enhance virus 
replication, or instead act to inhibit virus replication, is still unclear. 
Further studies focusing on these interactions are needed to reveal 
the interplay mechanism of host miRNAs and viruses, and the 
conserved interaction between miRNAs and S-OIV or SIV genes 
may be potential drug targets for anti-S-OIV or anti-SIV therapy. 
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Supplementary material 
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Where Xm is the expression value of any miRNA,  M X  and δM are the mean and standard deviation of all of the measured miRNA 
expression values, respectively. 
 
Table 1: the putative interactions between S-OIV HA genes derived from different isolated sources with the human miRNAs. 
GenBank  ID  Date  Country  hsa-miR-145 hsa-miR-92b hsa-miR-92a hsa-miR-339-5p 
FJ966952 30-Mar-09  USA:  California  state        + 
FJ966082 1-Apr-09  USA:  California        + 
GQ117044 1-Apr-09  USA:  California  state        + 
FJ969511 8-Apr-09  USA:  California  state        + 
FJ966974 9-Apr-09  USA:  California  state        + 
FJ969540 9-Apr-09  USA:  California  state        + 
FJ971076 9-Apr-09  USA:  California  state        + 
FJ981613 9-Apr-09  USA:  California  state        + 
FJ966982 14-Apr-09  USA:  Texas  state  +     + 
FJ981612 14-Apr-09  USA:  Texas  state  +     + 
FJ981615 14-Apr-09  USA:  Texas  state  +     + 
FJ966959 15-Apr-09  USA:  Texas  state  +     + 
FJ966971 15-Apr-09  USA:  California  state         
GQ122097 15-Apr-09  USA:  Texas  state        + 
FJ966960 16-Apr-09  USA:  California  state        + 
GQ117067 22-Apr-09  USA:  Arizona  state        + 
GQ117097  22-Apr-09  USA: Indiana state        + 
FJ984385 23-Apr-09  USA:  Texas  state  +     + 
FJ969521  24-Apr-09  USA: Ohio state         
FJ969523  24-Apr-09  USA: Kansas state         
FJ969535  24-Apr-09  USA: Ohio state         
FJ984360  24-Apr-09  USA: New York state        + 
FJ984364  24-Apr-09  USA: New York state        + 
FJ984397  24-Apr-09  USA: Ohio state        + 
FJ984401  24-Apr-09  USA: Ohio state        + 
GQ117024  24-Apr-09  USA: New York state        + 
GQ117051 24-Apr-09  USA:  Texas  state  +     + 
GQ117059  24-Apr-09  USA: Kansas state  +     + 
GQ117062  24-Apr-09  USA: Kansas state        + 
GQ117100  24-Apr-09  USA: Ohio state        + 
FJ973557 25-Apr-09  New  Zealand:  Auckland        + 
FJ984347  25-Apr-09  USA: New York state        + 
FJ984355  25-Apr-09  USA: New York state        + 
FJ984375  25-Apr-09  USA: New York state        + 
FJ984394  25-Apr-09  USA: New York state        + 
FJ984337  25-Apr-09  USA: New York state        + 
GQ117032 25-Apr-09  USA:  Texas  state  +     + 
GQ117040 25-Apr-09  USA:  California  state        + 
GQ117082  25-Apr-09  USA: New York state        + 
GQ117086  25-Apr-09  USA: New York state        + 
GQ117091 25-Apr-09  USA:  Texas  state        + 
GQ117103 25-Apr-09  USA:  Massachusetts  state        + 
GQ117116  25-Apr-09  USA: New York state        + 
CY039893  26-Apr-09  USA: Orange County, NY        + 
FJ985753 26-Apr-09  Spain:  Albacete,   
Castilla-La Mancha 
  +  +   
FJ985758 26-Apr-09  Spain:  Valencia    +  +   
FJ985763  26-Apr-09  Spain: Donostia, Pais Vasco         
FJ985768 26-Apr-09  Spain:  Albacete,   
Castilla-La Mancha 
  +  +   
GQ117043 26-Apr-09  USA:  Massachusetts  state        + 
GQ117056  26-Apr-09  USA: South Carolina state    +  +  + 
GQ117079 26-Apr-09  USA:  Arizona  state        + 
GQ117112 26-Apr-09  USA:  Michigan  state        + 
FJ974021 27-Apr-09  Germany:  Bavaria,  Regensburg        + Bioinformation   open access 
www.bioinformation.net    Hypothesis
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CY039901  27-Apr-09  USA: Suffolk County, NY        + 
GQ117119  27-Apr-09  USA: Colorado state         
CY039527 29-Apr-09  Netherlands:  Rotterdam        + 
FJ982430 29-Apr-09  Denmark        + 
GQ122105 30-Apr-09  Sweden:  Stockholms  Lan,   
Taby Kommun 
    + 
GQ131023 2-May-09  South  Korea        + 
FJ974022 9-Apr  Canada         
FJ974023 9-Apr  Canada         
FJ974024 9-Apr  Canada         
FJ974025 9-Apr  Canada         
FJ974026 9-Apr  Canada         
FJ974027 9-Apr  Canada         
FJ974028 9-Apr  Canada         
GQ122099 9-Apr  Spain:  Catalonia    +  +  + 
GQ122102 9-Apr  Spain:  Catalonia        + 
FJ969509  2009  USA: New York state        + 
FJ969542  2009  USA: New York state         
FJ998207  2009  Canada: Nova Scotia        + 
FJ998208 2009  Mexico        + 
FJ998209 2009  Canada:  Ontario        + 
GQ132142  2009  Canada: Nova Scotia        + 
GQ132143 2009  Canada:  Ontario        + 
GQ132144 2009  Canada:  Ontario        + 
GQ132145 2009  Mexico        + 
GQ132146 2009  Canada:  Alberta        + 
GQ132147  2009  Canada: Nova Scotia        + 
GQ132184 2009  Thailand        + 
+: this HA gene is putatively targeted by the corresponding miRNAs; the GenBank ID highlighted in grey indicates that this gene is partly 
sequenced and submitted to NCBI; the miRNA highlighted in yellow indicates that this putative miRNA-mediated host-virus interaction 
shows location-specificity. 